Ticker Scorecard - TVTX Basics Company: Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $1.91B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.53% Avg Daily Range (30 D): $0.58 | 2.85% Avg Daily Range (90 D): $0.47 | 2.47% Institutional Daily Volume Avg Daily Volume: .88M Avg Daily Volume (30 D): 1.35M Avg Daily Volume (90 D): 1.17M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 2,885 Avg Inst. Trade: $1.95M Avg Inst. Trade (30 D): $2.31M Avg Inst. Trade (90 D): $2.32M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.71M Avg Closing Trade (30 D): $4.88M Avg Closing Trade (90 D): $4.15M Avg Closing Volume: 162.4K     News Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Nov 13, 2024 @ 10:00 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Nov 8, 2024 @ 2:05 AM Travere Therapeutics Announces Pricing of Public O... Source: Globe Newswire Nov 8, 2024 @ 2:05 AM Travere Therapeutics Announces Pricing of Public O... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.7 $-.91 $-1.76 Diluted EPS $-.7 $-.91 $-1.76 Revenue $ 62.9M $ 54.12M $ 41.37M Gross Profit $ 61.27M $ 52.06M $ 39.87M Net Income / Loss $ -54.81M $ -70.41M $ -136.06M Operating Income / Loss $ -56.15M $ -67.7M $ -139.24M Cost of Revenue $ 1.63M $ 2.06M $ 1.5M Net Cash Flow $ 4.12M $ -10.96M $ -14.93M PE Ratio     Splits Nov 08, 2011:   9:1